Skye Bioscience SKYE
NASDAQ SKYE
$1.60 -0.01 (-0.62%)
As of: Oct 1, 2026 · 3:59 PM EDT

Skye Bioscience (SKYE) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Skye Bioscience's Depreciation & Amortization (CF) was $157,598 in Q2 2026, down 15.8% from $187,066 a year earlier and down 8.8% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Skye Bioscience's Depreciation & Amortization (CF) was $689,391 through Jun 30, 2026, up 13.8% year-over-year; for FY2025, it came in at $723,352, up 142.2% from FY2024.

  • Depreciation & Amortization (CF) has now increased for four consecutive years, with a five-year compound annual growth rate of 229.2% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $298,640 in FY2024 (+140.4%), $124,251 in FY2023 (+8.0%), $114,998 in FY2022 (+236.9%) and $34,131 in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q3 2024.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in five of the last seven quarters, with growth averaging 193.8%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2025 (growth of 543.6%); the worst was Q1 2024 (a decline of 16.9%).
  • Per Business Quant data, SKYE's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $172,886 (Q1 2026), $180,009 (Q4 2025) and $178,898 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Skye Bioscience 7.07 Mn 7.07 Mn - 157,598.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 157,598.00
Mar 31, 2026 172,886.00
Dec 31, 2025 180,009.00
Sep 30, 2025 178,898.00
Jun 30, 2025 187,066.00
Mar 31, 2025 177,379.00
Dec 31, 2024 175,293.00
Sep 30, 2024 65,997.00
Jun 30, 2024 29,790.00
Mar 31, 2024 27,560.00
Dec 31, 2023 -45,971.00
Sep 30, 2023 28,789.00
Jun 30, 2023 33,917.00
Mar 31, 2023 33,174.00
Dec 31, 2022 31,532.00
Sep 30, 2022 28,805.00
Jun 30, 2022 27,683.00
Mar 31, 2022 26,978.00
Dec 31, 2021 24,719.00
Sep 30, 2021 7,464.00
API Access

Skye Bioscience Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SKYE&period=max&api_key=YOUR_API_KEY